中期因子(MK)單克隆抗體

• 來源單抗制備
• 宿主小鼠
• 效價(克隆號)-
• Ig亞型IgG
• 純化方式抗原特異性親和純化
• 中期因子(MK)單克隆抗體標記物無標記物
• **原-
• 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
• 性狀液體
• 濃度500ug/ml
• 且適物種-
• 應用WB, ICC, IHC-P, IHC-F, ELISA
• 中期因子(MK)單克隆抗體Monoclonal Antibody to Midkine (MK)
  Organism Species: Homo sapiens (Human)
  Instruction manual
  FOR IN VITRO USE AND RESEARCH USE ONLY
  NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
  9th Edition (Revised in Jul, 2013)
  [ PRODUCT INFORMATION ]
  Immunogen: Midkine, Human
  Clonality: Monoclonal
  Clone number: B2
  Host: Mouse
  Immunoglobulin Type: IgG
  Purification: Affinity Chromatography.
  Applications: WB, ICC, IHC-P, IHC-F, ELISA
  Concentration: 500μg/mL
  UOM: 200μg Sample: Recombinant Midkine, Human
  中期因子(MK)單克隆抗體[ IMMUNOGEN INFORMATION ]
  Immunogen: Recombinant midkine (Ala22~Asp143) expressed in E.coli. Accession No.: RPA631Hu01
  Sequence: The target protein is fused with N-terminal His-Tag and its sequence
  is listed below.
  MHHHHHHSSG LVPRGSGMKE TAAAKFERQH MDSPDLGTDD DDKAMADIGS EFAKKK
  DKVK K GGPGS E CA EW AWGP CTPS SK DC GV GF REG T CGA QTQ RI R C
  RVP CNWKKEF GADCKYKFE N WGACDGGTGT KVRQGT LKKA RYNAQCQETI
  RVTKPCTPKT KAKAKAKKGK GKD
  [ ANTIBODY SPECIFITY ]
  The antibody is a mouse monoclonal antibody raised against midkine. It has been
  selected for its ability to recognize midkine in immunohistochemical staining and
  western blotting.
  [ APPLICATIONS ]
  Western blotting: 1:100-400
  Immunocytochemistry in formalin fixed cells: 1:100-500
  Immunohistochemistry in formalin fixed frozen section: 1:100-500
  Immunohistochemistry in paraffin section: 1:50-200
  Enzyme-linked Immunosorbent Assay: 1:100-200
  Optimal working dilutions must be determined by end user.
  [ CONTENTS ]
  Form & Buffer: Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  中期因子(MK)單克隆抗體[ STORAGE ]
  Store at 4
  oC for frequent use. Stored at -20oC to -80
  oC in a manual defrost freezer
  for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.